Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
149,8 INR | +0,47 % | +1,25 % | +7,92 % |
14/05 | PIRAMAL PHARMA LIMITED : recomendación de compra de Jefferies & Co. | ZM |
13/05 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
Resumen de negocios
Número de empleados: 6 295
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Global Pharma
87,0
%
| 22 356 | 72,2 % | 61 581 | 87,0 % | +175,45 % |
Over the Counter Products
11,6
%
| 7 420 | 24,0 % | 8 188 | 11,6 % | +10,35 % |
Distribution Fees
0,8
%
| - | - | 556 | 0,8 % | - |
Scrap
0,5
%
| - | - | 323 | 0,5 % | - |
Others
0,2
%
| - | - | 169 | 0,2 % | - |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
79,6
%
| - | - | 56 371 | 79,6 % | - |
India
20,4
%
| 30 950 | 100,0 % | 14 445 | 20,4 % | -53,33 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Peter DeYoung
CEO | Chief Executive Officer | 46 | 04/03/20 |
Vivek Valsaraj
PSD | President | 51 | 10/06/20 |
Vinay Agrawal
COO | Chief Operating Officer | 60 | 05/04/20 |
Gagan Borana
IRC | Investor Relations Contact | - | - |
Prasanth M. S.
SAM | Sales & Marketing | 51 | 10/06/20 |
Vikram Duggal
HRO | Human Resources Officer | 50 | 08/01/20 |
Sameer Penkar
SAM | Sales & Marketing | - | 10/06/20 |
Corporate Secretary | - | 04/03/20 | |
Rashida Najmi
PRN | Corporate Officer/Principal | 58 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 43 | 04/01/21 | |
Neeraj Bharadwaj
BRD | Director/Board Member | 55 | - |
Director/Board Member | 76 | 09/02/21 | |
Director/Board Member | 51 | 30/03/22 | |
Vibha Paul Rishi
BRD | Director/Board Member | 63 | 29/09/22 |
Director/Board Member | 64 | 09/02/21 | |
Peter DeYoung
CEO | Chief Executive Officer | 46 | 04/03/20 |
Vivek Valsaraj
PSD | President | 51 | 10/06/20 |
Peter Stevenson
BRD | Director/Board Member | - | 30/03/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 318 016 324 | 351 435 407 ( 26,66 %) | 0 | 26,66 % |
Información de la empresa
Piramal Pharma Ltd.
507, Skyline Wealth Space, 5th Floor C2 Wing, Skyline Oasis Complex
400086, Mumbai
+91 22 3802 3000
http://www.piramal.com/businesses/piramal-pharma/Ventas por actividad
Ventas por región
Revisiones del BPA
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,92 % | 2363,46 M | |
+32,09 % | 694 mil M | |
+29,39 % | 593 mil M | |
-1,34 % | 371 mil M | |
+20,34 % | 331 mil M | |
+7,39 % | 290 mil M | |
+14,25 % | 239 mil M | |
-3,03 % | 209 mil M | |
+10,02 % | 209 mil M | |
+8,49 % | 169 mil M |
- Bolsa de valores
- Acciones
- Acción PPLPHARMA
- Empresa Piramal Pharma Limited